Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer	Platinum-sensitive Relapsed Ovarian Cancer	Not yet recruiting	Phase 2	2024-06-06		NCT06446206

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The First Hospital of Jilin University	154

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials